News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,774 Results
Type
Article (14578)
Company Profile (282)
Press Release (258914)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (80683)
Career Advice (173)
Deals (13448)
Drug Delivery (35)
Drug Development (51120)
Employer Resources (32)
FDA (5815)
Job Trends (5317)
News (146555)
Policy (10206)
Tag
Academia (957)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (22172)
ALS (64)
Alzheimer's disease (874)
Antibody-drug conjugate (ADC) (100)
Approvals (5848)
Artificial intelligence (135)
Autoimmune disease (18)
Automation (6)
Bankruptcy (105)
Best Places to Work (4738)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (233)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (157)
Cancer (1494)
Cardiovascular disease (117)
Career advice (152)
Career pathing (3)
CAR-T (121)
Cell therapy (336)
Cervical cancer (8)
Clinical research (41595)
Collaboration (548)
Compensation (258)
Complete response letters (13)
COVID-19 (1098)
CRISPR (42)
C-suite (167)
Cystic fibrosis (76)
Data (1547)
Denatured (11)
Depression (31)
Diabetes (140)
Diagnostics (1361)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (86)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (30043)
Editorial (18)
Employer branding (4)
Employer resources (30)
Events (49206)
Executive appointments (470)
FDA (6531)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (504)
Gene editing (98)
Generative AI (11)
Gene therapy (258)
GLP-1 (368)
Government (1119)
Grass and pollen (2)
Guidances (22)
Healthcare (6746)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1164)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (67)
Interviews (21)
IPO (7354)
IRA (11)
Job creations (874)
Job search strategy (144)
Kidney cancer (7)
Labor market (5)
Layoffs (211)
Leadership (3)
Legal (1410)
Liver cancer (34)
Lung cancer (210)
Lymphoma (102)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (55)
Medical device (2675)
Medtech (2677)
Mergers & acquisitions (6432)
Metabolic disorders (393)
Multiple sclerosis (53)
NASH (14)
Neurodegenerative disease (69)
Neuropsychiatric disorders (25)
Neuroscience (1290)
NextGen: Class of 2025 (2074)
Non-profit (889)
Now hiring (22)
Obesity (194)
Opinion (105)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (123)
Partnered (9)
Patents (131)
Patient recruitment (78)
Peanut (35)
People (25984)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14662)
Phase II (19337)
Phase III (12271)
Pipeline (817)
Policy (45)
Postmarket research (870)
Preclinical (6200)
Press Release (31)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (298)
Real estate (1451)
Recruiting (12)
Regulatory (8774)
Reports (15)
Research institute (980)
Resumes & cover letters (20)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (62)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (42)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (2034)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (221)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (97)
Last 7 days (523)
Last 30 days (1537)
Last 365 days (19812)
2025 (6364)
2024 (20846)
2023 (22725)
2022 (27522)
2021 (28782)
2020 (23892)
2019 (16723)
2018 (12066)
2017 (14004)
2016 (12044)
2015 (14599)
2014 (10535)
2013 (7653)
2012 (7702)
2011 (7783)
2010 (7566)
Location
Africa (155)
Alabama (42)
Alaska (3)
Arizona (53)
Arkansas (5)
Asia (17646)
Australia (2971)
California (3889)
Canada (1149)
China (365)
Colorado (151)
Connecticut (160)
Delaware (102)
Europe (38018)
Florida (468)
Georgia (118)
Idaho (17)
Illinois (233)
India (11)
Indiana (96)
Iowa (2)
Japan (81)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (474)
Massachusetts (3132)
Michigan (70)
Minnesota (149)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (17)
New Jersey (989)
New Mexico (13)
New York (1056)
North Carolina (563)
North Dakota (6)
Northern California (1717)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (748)
Puerto Rico (6)
Rhode Island (19)
South America (212)
South Carolina (4)
Southern California (1495)
Tennessee (25)
Texas (462)
United States (13450)
Utah (56)
Virginia (79)
Washington D.C. (30)
Washington State (354)
Wisconsin (16)
273,774 Results for "domain therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer
Domain Therapeutics today announces the appointment of Sean A. MacDonald as its Chief Executive Officer (CEO).
April 17, 2024
·
3 min read
Press Releases
Revi® System Demonstrates Significant and Sustained Quality of Life Benefits Across All Domains for the Majority of Patients with Urgency Urinary Incontinence at 24 Months
April 30, 2025
·
5 min read
Press Releases
ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies
April 14, 2025
·
3 min read
Domain Therapeutics to Participate at Premier Investor and Healthcare Conferences
Domain Therapeutics announced its President and Chief Executive Officer, Anthony Johnson, M.D., and its Chief Business Officer, Sean A. MacDonald, will participate in the following investor, partnering and healthcare industry conferences in April-May, 2024: This press release features multimedia.
April 8, 2024
·
2 min read
Genetown
Domain Therapeutics Strengthens Its Intellectual Property for Its Series of Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012
Domain Therapeutics today announces the publication of three international PCT patent applications.
June 6, 2024
·
2 min read
Business
Domain Therapeutics Promotes Stephan Schann as Chief Scientific Officer (CSO)
Domain Therapeutics today announces the expansion of the Company’s executive management team with the appointment of Stephan Schann as Chief Scientific Officer (CSO).
February 27, 2024
·
3 min read
Press Releases
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company
September 30, 2024
·
8 min read
Business
Domain Therapeutics Further Strengthens Leadership Team With Appointment of Sean A. MacDonald as Chief Business Officer
Domain Therapeutics today announces the appointment of Sean A. MacDonald as its Chief Business Officer (CBO) and member of the executive management team.
February 8, 2024
·
3 min read
Biotech Bay
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
OmniAb, Inc. announced the publication of a peer-reviewed paper titled “Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies” in the Journal of Immunology demonstrating that chickens can be genetically engineered to produce functional heavy chain-only single-domain antibodies.
June 3, 2024
·
6 min read
Press Releases
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology
January 29, 2025
·
3 min read
1 of 27,378
Next
